fullerene c60 has been researched along with fluorescein in 3 studies
Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (fluorescein) | Trials (fluorescein) | Recent Studies (post-2010) (fluorescein) |
---|---|---|---|---|---|
3,806 | 5 | 2,170 | 6,214 | 283 | 2,082 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Doi, K; Fujita, T; Homma, T; Isobe, H; Maeda, R; Nakamura, E; Negishi, K; Noiri, E; Tanaka, T | 1 |
Cai, T; Hong, H; Hu, X; Lu, W; Peng, Y; Yang, D | 1 |
Bai, X; Chang, YN; Chen, K; Chen, X; Chen, Z; Kong, J; Li, J; Liang, H; Liang, W; Liang, Y; Mao, M; Wang, Y; Xia, S; Xing, G; Zhang, J | 1 |
3 other study(ies) available for fullerene c60 and fluorescein
Article | Year |
---|---|
A water-soluble fullerene vesicle alleviates angiotensin II-induced oxidative stress in human umbilical venous endothelial cells.
Topics: Adult; Angiotensin II; Apoptosis; Cell Line; Cell Survival; Chemical Phenomena; Chemistry, Physical; Endothelial Cells; Female; Flow Cytometry; Fluorescein; Fluoresceins; Fluorescent Dyes; Fullerenes; Humans; Hydroxyl Radical; Immunohistochemistry; Microscopy, Electron, Transmission; Oxidants; Oxidative Stress; Peroxynitrous Acid; Pregnancy; Reactive Oxygen Species; Solubility; Umbilical Veins | 2008 |
Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
Topics: Animals; Cell Line, Tumor; Computer Simulation; Copper Radioisotopes; Female; Fluorescein; Fullerenes; Glioblastoma; Humans; Kidney; Mice, Nude; Nanoparticles; Positron-Emission Tomography; Spectroscopy, Fourier Transform Infrared; Time Factors; Tissue Distribution | 2017 |
Intrinsic Biotaxi Solution Based on Blood Cell Membrane Cloaking Enables Fullerenol Thrombolysis
Topics: Animals; Biocompatible Materials; Cell Survival; Disease Models, Animal; Drug Carriers; Erythrocyte Membrane; Fibrinolysis; Fluorescein; Fullerenes; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Nanoparticles; Rats; Silicon Dioxide; Thrombosis; Tissue Distribution; Urokinase-Type Plasminogen Activator | 2020 |